The Conference Forum has been acquired by Questex LLC, the parent company of Fierce Healthcare & Life Sciences.
Editorial by Category
Modernizing Clinical Trial Operations
View All
Conference Forum Joins Fierce Life Sciences
The Trifecta of Protocol Review: Patients, Sites, and Sponsors Building Better Studies
Disruptive Innovations to Modernize Clinical Research: DPHARM 2025 Recap
How Paradigm Health Is Enabling Community and Rural Health Systems to Do Oncology Clinical Research
Immuno-Oncology and Cell Therapy
View All
Drug Delivery
View All
Conference Forum Joins Fierce Life Sciences
Implementing a Control Strategy for Combination Product Design and Manufacturing
Partnering for Combination Product Success: Higher-Level Collaboration that Delivers Higher ROI
Overcoming the Limitations of PLGA-Based Technologies to Enable Better Long-Acting Injectables
Patients as Partners in Clinical Research and Patient Access
View All
Conference Forum Joins Fierce Life Sciences
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Overcoming Reach and Recruitment Challenges to Engage Rare Disease Patients in Clinical Trials
How Boehringer Ingelheim’s Site Engagement Academy Is Helping to Create Empathetic Site Partnerships for Patient Benefit
Biotech CMO/R&D Leadership
View All
Community-Based Clinical Trials
View All
Conference Forum Joins Fierce Life Sciences
Building an Infrastructure to Drive More Effective Patient Enrollment and Retention: Partnerships with Sites Summit 2025 Recap
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Clinical Research as a Care Option: CRAACO 2025 Recap
Women Leadership in Biotech
View All
Commercializing Therapies Requires Patient-Centricity and Advocacy
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
How Sponsors Can Help Sites with Payment, Staffing and Technology
